Moleculin Biotech, Inc.
MBRX
$0.77
$0.011.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.96M | -50.14M | -43.20M | -65.33M | -40.47M |
| Total Depreciation and Amortization | 47.00K | 67.00K | 90.00K | 112.00K | 122.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.57M | 24.81M | 19.82M | 43.05M | 17.06M |
| Change in Net Operating Assets | 1.99M | 980.00K | 555.00K | -278.00K | 1.95M |
| Cash from Operations | -25.36M | -24.28M | -22.74M | -22.45M | -21.34M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.10M | 26.91M | 27.29M | 19.80M | 18.08M |
| Repurchase of Common Stock | -8.00K | -8.00K | -8.00K | 0.00 | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.09M | 26.90M | 27.28M | 19.80M | 18.08M |
| Foreign Exchange rate Adjustments | -25.00K | -14.00K | 51.00K | -48.00K | -28.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -295.00K | 2.60M | 4.60M | -2.70M | -3.29M |